Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2-overexpressing locally advanced breast cancers.
Assessment of PTEN and PI3K status in primary breast cancer and corresponding metastases: is it worthwhile? / Russillo, M.; Di Benedetto, A.; Metro, G.; Ferretti, G.; Papaldo, P.; Cognetti, F.; Mottolese, Marcella; Fabi, A.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 29:20(2011), pp. 2834-2835. [10.1200/JCO.2011.35.1742]
Assessment of PTEN and PI3K status in primary breast cancer and corresponding metastases: is it worthwhile?
Russillo M.;Cognetti F.;
2011
Abstract
Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2-overexpressing locally advanced breast cancers.File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Russillo_Assessment_2011.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
53.41 kB
Formato
Adobe PDF
|
53.41 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
